Pharmaceutical company stocks undervalued.

Published: 2002-06-13 06:59:00

Updated: 2002-06-13 06:59:00

Mirae Asset Security company reported on May 11 that the pharmaceutical company stocks in the bourse were undervalued without reflecting favorable business achievement as shown in their sales growth and a health company transformation since the last year. The company therefore strongly recommende...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK